MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital and the Center for Translational Transplant Medicine, Georgetown University Medical Center, Washington, District of Columbia.
Department of Pathology, MedStar Georgetown University Hospital, Washington, District of Columbia.
Am J Transplant. 2021 May;21(5):1878-1892. doi: 10.1111/ajt.16405. Epub 2021 Feb 17.
Graft-versus-host disease (GvHD) is a common, morbid complication after intestinal transplantation (ITx) with poorly understood pathophysiology. Resident memory T cells (T ) are a recently described CD69+ memory T cell subset localizing to peripheral tissue. We observed that T effector memory cells (T ) in the blood increase during GvHD and hypothesized that they derive from donor graft CD69+T migrating into host blood and tissue. To probe this hypothesis, graft and blood lymphocytes from 10 ITx patients with overt GvHD and 34 without were longitudinally analyzed using flow cytometry. As hypothesized, CD4+ and CD8+CD69+T were significantly increased in blood and grafts of GvHD patients, alongside higher cytokine and activation marker expression. The majority of CD69+T were donor derived as determined by multiplex immunostaining. Notably, CD8/PD-1 was significantly elevated in blood prior to transplantation in patients who later had GvHD, and percentages of HLA-DR, CD57, PD-1, and naïve T cells differed significantly between GvHD patients who died vs. those who survived. Overall, we demonstrate that (1) there were significant increases in T at the time of GvHD, possibly of donor derivation; (2) donor T in the graft are a possible source; and (3) potential biomarkers for the development and prognosis of GvHD exist.
移植物抗宿主病(GvHD)是肠移植(ITx)后的一种常见且严重的并发症,其发病机制尚不清楚。驻留记忆 T 细胞(T 细胞)是最近描述的一种 CD69+记忆 T 细胞亚群,定位于外周组织。我们观察到,GvHD 期间血液中的效应记忆 T 细胞(T 细胞)增加,并假设它们来源于移植物中 CD69+T 细胞向宿主血液和组织的迁移。为了验证这一假设,我们对 10 例有明显 GvHD 的 ITx 患者和 34 例无 GvHD 的患者的移植物和血液淋巴细胞进行了纵向分析,使用流式细胞术。正如假设的那样,GvHD 患者的血液和移植物中 CD4+和 CD8+CD69+T 细胞明显增加,同时细胞因子和激活标志物的表达也更高。通过多重免疫染色确定,大多数 CD69+T 细胞来源于供体。值得注意的是,在发生 GvHD 的患者中,在移植前血液中 CD8/PD-1 明显升高,且 HLA-DR、CD57、PD-1 和幼稚 T 细胞的比例在死亡和存活的 GvHD 患者之间有显著差异。总体而言,我们证明了(1)在 GvHD 发生时 T 细胞数量显著增加,可能来源于供体;(2)移植物中的供体 T 细胞可能是其来源;(3)存在用于 GvHD 发展和预后的潜在生物标志物。